Flow cytometric immunophenotyping of HSPCs was done on stored frozen viable mononuclear cells (MNCs) from PB and/or BM samples obtained from individuals with SDS aged 4–33 years or from healthy/non-SDS donors aged 29–32 years (STEMCELL Technologies). MNCs from healthy (non-SDS) donors were stained with antibodies:
CD3-FITC (clone HIT3a, BD #555339; dilution 1:500),
CD90-PE (clone 5E10, Biolegend, #328114; 1:33), CD49f-PECy5 (clone GoH3, BD #551129; 1:100),
CD38-PECy7 (clone HIT2, Biolegend, #303516; 1:100),
CD33-APC (clone WM53, BD #571817; 1:200),
CD19-A700 (clone HIB19, Biolegend #302226; 1:300),
CD34-APCCy7 (clone 581, Biolegend #343514; 1:100),
CD45RA-BV421 (clone HI100, Biolegend #304130; 1:100), and
Zombie Aqua (Biolegend #423101; 1:2000). MNCs from individuals with SDS were stained with the following antibodies:
CD38-FITC (clone HIT2, BD #555459; 1:12.5),
CD34-PE-Cy7 (clone 8G12, BD #348811; 1:33), CD10-BV605 (clone HI10a, Biolegend #312222: 1:33),
CD45RA-V450 (clone HI30, BD #560367; 1:100),
CD90 APC (Clone 5E10, Biolegend #328110; 1:50),
CD3-APC-Cy7 (clone SK7, Biolegend #344818; 1:50), and
CD19-APC-Cy7 (clone HIB19, Biolegend #302218, 1:50). After gating for live singlets (7AAD or Zombie negative) and excluding CD3/CD19 positive cells, bulk CD34 positive progenitors were gated (Supplementary Fig.
1).
Machado H.E., Øbro N.F., Williams N., Tan S., Boukerrou A.Z., Davies M., Belmonte M., Mitchell E., Baxter E.J., Mende N., Clay A., Ancliff P., Köglmeier J., Killick S.B., Kulasekararaj A., Meyer S., Laurenti E., Campbell P.J., Kent D.G., Nangalia J, & Warren A.J. (2023). Convergent somatic evolution commences in utero in a germline ribosomopathy. Nature Communications, 14, 5092.